Bay's stock price target has seen a modest uptick, with consensus analyst estimates moving from $91.55 to $94.93. This subtle shift reflects a mix of analyst optimism and healthy skepticism, fueled by ...

Teads Holding's stock outlook has shifted notably, as the Fair Value Estimate was recently lowered from $3.02 to $1.85 per share. This change has been driven by a mix of cautious analyst sentiment, ...

Assembly Biosciences is experiencing a dramatic stock rally following the release of groundbreaking clinical trial results.

Discover key takeaways from The RMR Group's Q4 2025 earnings call, including earnings guidance, REIT strategies, and market risks.

Get key insights from Lument Finance Trust's Q3 2025 earnings call—discover strategies, risk management, and new growth opportunities.

CoreWeave (NASDAQ:CRWV) reported Q3 results, and the numbers were impressive – revenue more than doubled from last year, and losses narrowed as ...

Madrigal Pharmaceuticals (MDGL) announced positive two-year data from the open-label compensated MASH cirrhosis arm of the Phase 3 MAESTRO-NAFLD-1 ...

In the assessment of 12-month price targets, analysts unveil insights for CoreWeave, presenting an average target of $151.73, ...

The investment community is buzzing with renewed optimism for Robinhood Markets following the fintech platform's impressive third-quarter earnings release. M ...

Intellia Therapeutics (NASDAQ: NTLA) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of ...